Drugs / Anterior lamellar nanostructured artificial human cornea
Anterior lamellar nanostructured artificial human cornea
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01765244 | Jan 2014 → Jan 2021 | corneal ulcer | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anterior lamellar nanostructured artificial human cornea | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01765244 ↗ |
| Modality | Other / unclassified | “bioengineered human anterior corneal substitute” NCT01765244 ↗ |
| Route | Other | “Implantation of an anterior lamellar nanostructured artificial human cornea with allogeneic cells from dead donors embedded in a fibrin-agarose scaffold” NCT01765244 ↗ |